Cash Flow Alphamab Oncology Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
180.00
-232.00
-378.00
-497.00
-480.00
-944.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
14.00
8.00
45.00
45.00
4.00
-13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
293.00
-173.00
-327.00
-335.00
-369.00
-243.00
Cash Flow from Investing Activities
-174.00
-83.00
944.00
623.00
-1,745.00
-763.00
Cash Flow from Financing Activities
-97.00
253.00
-339.00
456.00
222.00
2,406.00
Net Cash Inflow / Outflow
28.00
18.00
309.00
744.00
-1,890.00
1,399.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
6.00
21.00
30.00
0.00
1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Alphamab Oncology
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
180.351962409865
-315.203387045191
495.00
157.22%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
14.2228483659726
151.381501338148
-137.00
-90.60%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
293.904893883036
55.6380307019553
238.00
428.24%
Cash Flow from Investing Activities
-174.444026692059
-184.275768495889
10.00
5.34%
Cash Flow from Financing Activities
-97.2906580594465
37.5412505467145
-134.00
-359.16%
Net Cash Inflow / Outflow
28.3351059000097
-90.5565437736517
118.00
131.29%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
6.16489676847996
0.539943473567186
6.00
1041.77%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 269.89% vs 47.10% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
293.90
-173.00
269.89%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
